|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07D 498/04 | (2006.01) |
| C07D 513/04 | (2006.01) | ||
| A61K 31/437 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 3094329 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15735499.4 |
| Europos patento paraiškos padavimo data | 2015-01-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-11-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-09-26 |
| (46) | Apibrėžties vertimo paskelbimo data | 2018-11-26 |
| (86) | Numeris | PCT/IB2015/050217 |
| Data | 2015-01-12 |
| (87) | Numeris | WO 2015/104688 |
| Data | 2015-07-16 |
| (30) | Numeris | Data | Šalis |
| 158CH2014 | 2014-01-13 | IN | |
| 3000CH2014 | 2014-06-20 | IN |
| (72) |
GUMMADI, Venkateshwar, Rao, IN
SAMAJDAR, Susanta, IN
|
| (73) |
Aurigene Oncology Limited ,
39-40 KIADB Industrial Area
Electronic City Phase II
Hosur Road, Bangalore 560100,
IN
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Bicikliniai heterociklilo dariniai kaip IRAK4 inhibitoriai |
| BICYCLIC HETEROCYCLYL DERIVATIVES AS IRAK4 INHIBITORS |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2025-12-18 | 12 | 289.00 EUR |
| 2027-01-12 |